Medicine
Orgovyx 120 mg tablet
Orgovyx 120 mg tablet is a prescription medicine containing Relugolix for oral use, marketed by Sumitomo Pharma, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store ORGOVYX at room temperature. Do not store above 30°C (86°F).
Key facts
- Active ingredient (INN)
- Relugolix
- Brand
- Orgovyx
- Strength
- 120 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets
- Marketing authorisation holder
- Sumitomo Pharma
- Manufacturer
- Sumitomo Pharma
- Origin register
- US FDA, United States
- Storage
- Store ORGOVYX at room temperature. Do not store above 30°C (86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L02BX Hormonal cancer treatments, subgroup L02B, subgroup L02BX
- HS code (indicative)
- 3004.39Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 18 December 2020
- Identifiers
- RxCUI 2472783, 2472789DailyMed set ID 077a92f6-9f1b-479a-87c7-c92b5db6aa9cNDC 72974-120Application NDA214621
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet, film coated in 1 bottle, plastic | 72974-120-01 | Sumitomo Pharma | 18 December 2020 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Relugolix is a gonadotropin releasing hormone receptor antagonist indicated for the treatment of adult patients with advanced prostate cancer. It is available as tablets for oral use. MedsAcross supplies Relugolix for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about RelugolixFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Orgovyx prescribing information (Sumitomo Pharma) · U.S. National Library of Medicine, DailyMed
- Orgovyx: European public assessment report (EPAR) · European Medicines Agency
Need Orgovyx 120 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.